To view the latest corporate presentation please click here.

CLICK HERE to view a copy of the presentation made by Pravin Dugel MD on 12 October 2019 at the American Academy of Ophthalmology Annual Meeting (AAO) in San Francisco relating to the Company’s Phase 1/2a clinical trial of its hRPC stem cell therapy in retinitis pigmentosa (RP).

To view the presentation being made at the AGM on 12 September at 10.00am please click here.